LIGAND PHARMACEUTICALS INCORPORATED (LGND) /

The profitability of LIGAND PHARMACEUTICALS INCORPORATED over the past 10 years

Chart LIGAND PHARMACEUTICALS INCORPORATED: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

LIGAND PHARMACEUTICALS INCORPORATED reported net income of $124.45M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $41M. It reported a profit in 6 of the 10 years shown, and a loss in fiscal 2016, 2020, 2022 and 2024. Its highest net income in these years was $629.3M, in fiscal 2019.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025—$41M$124.45M
2024ended Dec 31, 2024—-$22.61M-$4.03M
2023ended Dec 31, 2023—$11.94M$52.15M
2022ended Dec 31, 2022—$3.04M-$33.36M
2021ended Dec 31, 2021—$103.85M$57.14M
2020ended Dec 31, 2020—$37.5M-$2.98M
2019ended Dec 31, 2019—$807.08M$629.3M
2018ended Dec 31, 2018$245.12M*$163.73M$143.32M
2017ended Dec 31, 2017$135.74M*$68.08M$12.56M
2016ended Dec 31, 2016$103.4M*$43.88M-$1.64M

Fiscal years as LIGAND PHARMACEUTICALS INCORPORATED reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on LIGAND PHARMACEUTICALS INCORPORATED

Companies of a similar size

Not investment advice. This page shows what LIGAND PHARMACEUTICALS INCORPORATED filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.